Dianabol Inj 50mg

Dragon Pharma Dianabol Inj 50 — Pharmaceutical-Grade Injectable Methandienone

Dragon Pharma Dianabol Inj 50 is a parenteral anabolic solution delivering 50 mg of methandienone per milliliter in a high-quality oil carrier.

Designed for athletes pursuing rapid hypertrophy and strength accretion, this injectable formulation bypasses hepatic first-pass metabolism. It preserves the potent anabolic activity that established methandrostenolone as a cornerstone of mass-building pharmacology.

Overview

This oil-based suspension represents a refined iteration of the classic oral bulking agent, engineered for intramuscular delivery.

Each batch undergoes independent third-party laboratory analysis to verify concentration accuracy, purity, and sterility.

With a 4.5–6 hour elimination half-life, Dragon Pharma Dianabol Inj maintains stable plasma levels when administered daily or every other day.

The parenteral route markedly reduces hepatotoxic burden compared to oral tablets. This enables longer cycle durations without compromising the aggressive nitrogen retention and protein synthesis characteristic of methandienone.

Benefits

• Superior Bioavailability: Bypasses gastrointestinal degradation and hepatic first-pass metabolism. It achieves approximately 60–70% lower liver strain while maximizing systemic absorption of the active compound.
• Rapid Strength Accretion: Stimulates erythropoiesis and glycogenolysis, frequently producing measurable power increases within the first 5–7 days of administration.
• Substantial Hypertrophy: Supports significant lean mass accumulation—typically 8–15 pounds over a 6–8 week cycle—when paired with hypercaloric nutrition and progressive resistance training.
• Flexible Cycle Integration: Functions effectively as a frontload for extended testosterone-based bulking stacks. It also works as a standalone compound in shorter, focused mass phases.
• Verified Potency Assurance: Independent laboratory analysis dated October 2024 confirmed an actual concentration of 57.6 mg/mL. This exceeds the stated 50 mg/mL and ensures precise dosing calculations.

Main Features

• Oil-based injectable suspension with 0.22-micron sterile filtration
• Pharmaceutical-grade carrier oils and benzyl alcohol preservative system
• Moderate-to-high aromatization profile requiring proactive estrogen management
• Short active half-life supporting flexible daily or alternate-day injection scheduling
• Compatible with co-administration alongside other oil-based anabolic compounds
• Rigorous quality control protocols with third-party analytical verification

Ingredients

Each milliliter contains 50 mg of methandienone (methandrostenolone) as the active pharmaceutical ingredient.

The formulation utilizes pharmaceutical-grade carrier oils, benzyl alcohol as an antimicrobial preservative, and co-solvents to ensure stable suspension and optimal pharmacokinetics.

All raw materials undergo independent verification for identity, potency, and absence of microbial contamination prior to compounding.

How to Use

Administer via deep intramuscular injection into large muscle groups. Rotate between the gluteal region, vastus lateralis, and deltoid sites to prevent localized tissue fibrosis.

Warm the vial gently to body temperature before drawing to reduce viscosity. Always aspirate the syringe prior to depressing the plunger to confirm extravascular placement.

Maintain strict aseptic technique. Cleanse the rubber septum with isopropyl alcohol before each penetration. Utilize sterile needles for every administration, and never share injection equipment.

Store unopened vials in a temperature-stable environment between 15–30°C (59–86°F), shielded from direct light. Once accessed, consume within 60 days.

Dosage

Novice users should initiate therapy at 50 mg administered every other day. This assesses individual tolerance and androgenic response.

Intermediate and advanced athletes may escalate to 100 mg every other day. Alternatively, distribute 50 mg daily for more aggressive anabolic stimulation.

Due to the compound's brief half-life, dosing intervals should not exceed 48 hours. This maintains consistent receptor saturation.

Cycle duration typically spans 6–8 weeks when employed as a frontload for extended bulking stacks. It may extend to 8–10 weeks as a standalone mass-building compound.

Always incorporate appropriate liver support and estrogen control ancillaries throughout the protocol.

Side Effects

Despite the marked reduction in hepatotoxicity relative to oral counterparts, hepatic enzyme elevations may still occur. This is particularly true during prolonged or high-dose protocols.

Regular liver function monitoring is strongly advised.

The moderate-to-high aromatization rate predisposes users to estrogenic manifestations. These include peripheral edema, gynecomastia, and elevated blood pressure. Prophylactic aromatase inhibitor use is recommended.

Androgenic sequelae such as acne vulgaris, accelerated androgenetic alopecia in genetically susceptible individuals, and increased irritability are dose-dependent. They are manageable through dose modulation.

Exogenous androgen administration suppresses the hypothalamic-pituitary-gonadal axis. Temporary infertility and reduced endogenous testosterone secretion are expected physiological responses.

Safety Information

This product is intended exclusively for research purposes and use by qualified adults under appropriate supervision. Keep out of reach of children and minors.

Do not administer if you have a history of hepatic dysfunction, cardiovascular disease, or hormone-sensitive malignancies.

Discontinue use and seek immediate medical evaluation if you experience severe abdominal pain, jaundice, dyspnea, or chest discomfort.

Concurrent use with hepatotoxic substances significantly increases hepatic risk.

A comprehensive post-cycle therapy protocol incorporating Selective Estrogen Receptor Modulators (SERMs) must commence within 3–5 days following the final injection. This restores endogenous testosterone production.

Hepatoprotective supplements containing N-acetylcysteine (NAC), milk thistle, and TUDCA are strongly recommended during and immediately following the cycle.